ACE2 News and Research

RSS
Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

Researchers evaluate predictors for mortality in hospitalized COVID-19 patients

Researchers evaluate predictors for mortality in hospitalized COVID-19 patients

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Frail and older males more vulnerable to COVID-19 than females

Frail and older males more vulnerable to COVID-19 than females

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Convalescent antibodies do not enhance SARS-CoV-2 infection

Convalescent antibodies do not enhance SARS-CoV-2 infection

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

Researchers receive grant to find answers to taste loss in COVID patients

Researchers receive grant to find answers to taste loss in COVID patients

Do anti-nucleocapsid antibodies affect COVID-19 immune reactions?

Do anti-nucleocapsid antibodies affect COVID-19 immune reactions?

Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Conformational variation of the SARS-CoV-2 energy landscape

Conformational variation of the SARS-CoV-2 energy landscape

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

In silico screening of natural ACE2 inhibitors

In silico screening of natural ACE2 inhibitors

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

Novel genetic relationships with severe SARS-CoV-2

Novel genetic relationships with severe SARS-CoV-2

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.